Filing metadata

Accession number
0001661539-22-000005
Form type
Form 4
Filer
Tarsus Pharmaceuticals, Inc.
CIK
CIK 1819790
Filed
Feb 03, 2022
Reporting period
Feb 01, 2022
Description
Insider transaction

Explore SEC Filings Hub